Health Economics
1992 - 2025
Current editor(s): Alan Maynard, John Hutton and Andrew Jones From John Wiley & Sons, Ltd. Bibliographic data for series maintained by Wiley Content Delivery (). Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.
Volume 10, issue 8, 2001
- How reliable are hospital efficiency estimates? Exploiting the dual to homothetic production pp. 683-698

- Sherman T. Folland and Richard A. Hofler
- Family health effects: complements or substitutes pp. 699-714

- Michael Lee Ganz
- Twenty years of health care economic analysis in Spain: are we doing well? pp. 715-729

- Anna García‐Altés
- Changing the first line drug for malaria treatment—cost‐effectiveness analysis with highly uncertain inter‐temporal trade‐offs pp. 731-749

- Catherine A. Goodman, Paul G. Coleman and Anne J. Mills
- Economic evaluations of hepatitis B immunization: a global review of recent studies (1994–2000) pp. 751-774

- Philippe Beutels
- Methodological limitations of economic evaluations of antenatal screening pp. 775-778

- Stavros Petrou
- Representing uncertainty: the role of cost‐effectiveness acceptability curves pp. 779-787

- Elisabeth Fenwick, Karl Claxton and Mark Sculpher
Volume 10, issue 7, 2001
- Should we aggregate relative or absolute changes in QALYs? pp. 573-577

- Magnus Johannesson
- The desirability of a condition versus the well being and worth of a person pp. 579-581

- Erik Nord
- The ‘fair innings argument’ deserves a fairer hearing! comments by Alan Williams on Nord and Johannesson pp. 583-585

- Alan Williams
- Discounting for health effects in cost–benefit and cost‐effectiveness analysis pp. 587-599

- Hugh Gravelle and Dave Smith
- The impact of non‐compliance on the cost‐effectiveness of pharmaceuticals: a review of the literature pp. 601-615

- Dyfrig A. Hughes, Adrian Bagust, Alan Haycox and Tom Walley
- Analysing public preferences for cancer screening programmes pp. 617-634

- Dorte Gyrd‐Hansen and Jes Søgaard
- Paradigms and research programmes: is it time to move from health care economics to health economics? pp. 635-649

- Rhiannon Tudor Edwards
- The physician–patient relationship as a game of strategic information transmission pp. 651-668

- Kris De Jaegher and Marc Jegers
- Econometric issues in testing the age neutrality of health care expenditure pp. 669-671

- Christian Salas and James P. Raftery
- Reply to: econometric issues in testing the age neutrality of health care expenditure pp. 673-674

- Peter Zweifel, Stefan Felder and Markus Meier
- Affordability and cost‐effectiveness: decision‐making on the cost‐effectiveness plane pp. 675-680

- P. Pedram Sendi and Andrew H. Briggs
- Telemedicine and Telehealth: Principles, Policies, Performance and Pitfalls by Adam W. Darkins and Margaret A. Cary. Free Association Books, London, 2000. No. of pages 316. ISBN 1‐853‐43518‐X pp. 681-682

- W. David Bradford
- Clinical Guidelines. From Conception to Use, edited by Martin Eccles and Jeremy Grimshaw. Radcliffe Medical Press, Oxford, UK, 2000. No. of pages: 120. ISBN 1‐85775‐426‐3 pp. 682-682

- Ian Watt
Volume 10, issue 6, 2001
- The private finance initiative: a public finance illusion? pp. 479-486

- Diane Dawson
- The relative sensitivity of willingness‐to‐pay and time‐trade‐off to changes in health status: an empirical investigation pp. 487-497

- Richard D. Smith
- Cost‐effectiveness analysis with risk aversion pp. 499-508

- Joshua Graff Zivin
- The impact of problem drinking on employment pp. 509-521

- Weiwei Feng, Wei Zhou, J. Butler, Brenda M. Booth and Michael French
- Estimating hospital costs with a generalized Leontief function pp. 523-538

- Tong Li and Robert Rosenman
- Cost efficiency of US hospitals: a stochastic frontier approach pp. 539-551

- Michael D. Rosko
- Testing efficacy with detection controlled estimation: an application to telemedicine pp. 553-564

- W. David Bradford, Andrew N. Kleit, M. A. Krousel‐Wood and Richard N. Re
- Equity in Swedish health care reconsidered: new results based on the finite mixture model pp. 565-572

- Ulf-G. Gerdtham and Pravin Trivedi
Volume 10, issue 5, 2001
- Guest editors' introduction pp. 369-370

- Andrew Jones and Owen O'Donnell
- A discrete random effects probit model with application to the demand for preventive care pp. 371-383

- Partha Deb
- The performance of sample selection estimators to control for attrition bias pp. 385-398

- Astrid Grasdal
- Estimating treatment effects in randomized clinical trials with non‐compliance: the impact of maternal smoking on birthweight pp. 399-410

- Barton Hamilton
- Proportional treatment effects for count response panel data: effects of binary exercise on health care demand pp. 411-428

- Myoung-jae Lee and Satoru Kobayashi
- Live long, live well: quantifying the health of heterogeneous populations pp. 429-440

- John Mullahy
- The effect of variable health insurance deductibles on the demand for physician visits pp. 441-456

- Martin Schellhorn
- Effects of cost sharing on physician utilization under favourable conditions for supplier‐induced demand pp. 457-471

- Carine Van De Voorde, Eddy Van Doorslaer and Erik Schokkaert
- Stochastic league tables: communicating cost‐effectiveness results to decision‐makers pp. 473-477

- Raymond C.W. Hutubessy, Rob M.P.M. Baltussen, David B. Evans, Jan J. Barendregt and Christopher J.L. Murray
Volume 10, issue 4, 2001
- Science or marketing at who? A response to Williams pp. 277-282

- Christopher J.L. Murray, Julio Frenk, David Evans, Kei Kawabata, Alan Lopez and Orvill Adams
- Science or marketing at who? Rejoinder from Alan Williams pp. 283-285

- Alan Williams
- The role of permanent income and family structure in the determination of child health in Canada pp. 287-302

- Lori Curtis, Martin D. Dooley, Ellen L. Lipman and David Feeny
- A framework for cost‐effectiveness analysis from clinical trial data pp. 303-315

- Anthony O'Hagan and John W. Stevens
- Recognizing diversity in public preferences: The use of preference sub‐groups in cost‐effectiveness analysis pp. 317-324

- Mark Sculpher and Amiram Gafni
- Provider payment reform in China: the case of hospital reimbursement in Hainan province pp. 325-339

- Chi-Man (Winnie) Yip and Karen Eggleston
- The effect of health on acute care supplemental insurance ownership: an empirical analysis pp. 341-350

- Amir Shmueli
- Private and social time preferences for health and money: an empirical estimation pp. 351-356

- Angelina Lazaro, Ramon Barberan and Encarnacion Rubio
- The impact of income inequality on individual and societal health: absolute income, relative income and statistical artefacts pp. 357-361

- John Wildman
- Cost prediction models for the comparison of two groups pp. 363-366

- Andrew R. Willan and Bernie J. O'Brien
- The Economic Analysis of Substance Use and Abuse: An Integration of Econometric and Behavioral Economic Research edited by F.J. Chaloupka, M. Grossman, W.K. Bickel and H. Safer. University of Chicago Press, Chicago, 1999. No. of pages 383. ISBN 0‐226‐10047‐2 pp. 367-368

- Michael French
- The Politics of Emerging and Resurgent Infectious Diseases edited by Jim Whitman. Macmillan Press, Basingstoke, 2000. No. of pages 223. ISBN 0‐333‐69127‐X pp. 368-368

- Tom Jefferson
Volume 10, issue 3, 2001
- Equity considerations in health care: the relevance of claims pp. 187-205

- Xavier Cuadras‐Morató, José‐Luis Pinto‐Prades and José‐María Abellán‐Perpiñán
- Targeted health insurance in a low income country and its impact on access and equity in access: Egypt's school health insurance pp. 207-220

- Chi-Man (Winnie) Yip and Peter Berman
- Demand for traditional medicine in Taiwan: a mixed Gaussian–Poisson model approach pp. 221-232

- Steven T. Yen, Chao‐Hsiun Tang and Shew‐Jiuan B. Su
- On the societal value of health care: what do we know about the person trade‐off technique? pp. 233-243

- Colin Green
- The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study pp. 245-256

- Ruth Etzioni, Scott D. Ramsey, Kristin Berry and Martin Brown
- Alcohol abuse and economic conditions: Evidence from repeated cross‐sections of individual‐level data pp. 257-270

- Thomas Dee
- Reconsideration of discharge data to measure competition in the hospital industry pp. 271-276

- Eric Nauenberg, Yuri Andrijuk and Matthew Eisinger
Volume 10, issue 2, 2001
- Science or marketing at WHO? A commentary on ‘World Health 2000’ pp. 93-100

- Alan Williams
- Alternative approaches to obtain optimal bid values in contingent valuation studies and to model protest zeros. Estimating the determinants of individuals' willingness to pay for home care services in day case surgery pp. 101-118

- Eulàlia Dalmau‐Matarrodona
- Strategic interaction among hospitals and nursing facilities: the efficiency effects of payment systems and vertical integration pp. 119-134

- Dwayne Banks, Elliott Parker and Jeanne Wendel
- Health insurance and health services utilization in Ireland pp. 135-145

- Colm Harmon and Brian Nolan
- Searching for a better willingness to pay elicitation method in rural Nigeria: the binary question with follow‐up method versus the bidding game technique pp. 147-158

- Obinna Onwujekwe
- Citizens, their agents and health care rationing: an exploratory study using qualitative methods pp. 159-174

- Joanna Coast
- Aging and health care expenditures: A comment on Zweifel, Felder and Meiers pp. 175-177

- Thomas E. Getzen
- The death of cost‐minimization analysis? pp. 179-184

- Andrew H. Briggs and Bernie J. O'Brien
Volume 10, issue 1, 2001
- The world‐wide growth in obesity: an economic research agenda pp. 1-7

- Tomas Philipson
- Physicians' payment contracts, treatment decisions and diagnosis accuracy pp. 9-25

- Izabela Jelovac
- A comparison of scoring weights for the EuroQol© derived from patients and the general public pp. 27-37

- Daniel Polsky, Richard J. Willke, Karen Scott, Kevin A. Schulman and Henry A. Glick
- Theory versus practice: a review of ‘willingness‐to‐pay’ in health and health care pp. 39-52

- Jan Abel Olsen and Richard D. Smith
- Parameter solicitation for planning cost effectiveness studies with dichotomous outcomes pp. 53-66

- Martin W. McIntosh, Scott D. Ramsey, Kristin Berry and Nicole Urban
- Preventable illness and out‐of‐area travel of children in New York counties pp. 67-78

- Jayasree Basu and Bernard Friedman
- Economic evaluation alongside n‐of‐1 trials: getting closer to the margin pp. 79-82

- Jonathan Karnon and Nawab Qizilbash
- International health care reform: a legal, economic and political analysis. Edited by C.M. Flood. Routledge, London (2000). 315 pages. ISBN 0 415 20844 0 pp. 83-84

- Gwyn Bevan
- Clinical governance in primary care. Edited by T. van Zwanenberg and J. Harrison. Radcliffe Press Ltd., (1999). 199 pages. ISBN 1 85775 3968 pp. 84-84

- Garry Barton
- The changing hospital industry: comparing not‐for‐profit and for‐profit institutions. Edited by David M. Cutler. Chicago University Press, Chicago (2000). 384 pages, US$53.00. ISBN 0 226 13219 6 pp. 85-86

- Peter C. Smith and Andrew Street
- Health reform: public success, private failure. Edited by Daniel Drache and Terry Sullivan. Routledge, London (1999). 366 pages. ISBN 0 415 20236 1 pp. 86-87

- Charles Normand
- The global challenge of health care rationing. Edited by A. Coulter and C. Ham. Open University Press, Buckingham (2000). 267 pages. ISBN 0 335 20463 5 pp. 86-86

- Ray Robinson
- Pricing life: the controversial role of cost‐effectiveness in health care. Edited by Peter A Ubel. MIT Press, Cambridge, MA (2000). xix+208 pages, £16.95. ISBN 0 262 21016 9 pp. 87-88

- Alan Williams
- Drugs dilemmas and choices by a working party of the Royal College of Psychiatrists and the Royal College of Physicians. Gaskell, London, UK (2000). 291 pages. ISBN 1 901242 44 7.. Drugs and the law: report of the independent inquiry into the Misuse of Drugs Act 1971 by The Police Foundation, London, UK (2000). 148 pages. ISBN 0 947692 47 9 pp. 88-89

- Christine Godfrey
| |